Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-04

Clinical Trial Update: Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) [Phase 4]

View source ↗

Summary

Phase 4 randomized controlled trial investigating therapeutic escalation for moderate postoperative recurrence in Crohn's disease (POMEROL trial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn Disease | Phase 4 | Status: UNKNOWN